Skip to main content
Clinical Trials/NCT02558712
NCT02558712CompletedNot Applicable

Prospective Comparison of Technology-based Eye Care Services (TECS) With and Without OCT Assessment Versus Standard Face to Face Ophthalmologic Exam

Emory University2 sites in 1 country256 target enrollmentStarted: March 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
256
Locations
2
Primary Endpoint
Number of patients with accurate diagnosis of eye diseases from TECS protocol versus face to face eye exam with and without OCT

Study Overview

Brief Summary

The purpose of this study is to compare the Technology-based Eye Care Services (TECS) protocol to the standard face to face ophthalmologic exam.

Detailed Description

Patients will sign informed consent to enter the one visit study. They will undergo the study protocol and then see the face to face physician on the same day.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient at the Atlanta VA Medical Center (VAMC) New Comprehensive eye clinic

Exclusion Criteria

  • Known acute or chronic ocular issues

Arms & Interventions

Face to face exam

Other

Standard of clinical care, 8 point eye exam

Intervention: Technology-based Eye Care Services (TECS) Protocol (Other)

Outcomes

Primary Outcomes

Number of patients with accurate diagnosis of eye diseases from TECS protocol versus face to face eye exam with and without OCT

Time Frame: Evaluation Visit (Day 0)

Clinical diagnosis in dichotomous (yes/no) decision tree. The clinical diagnosis of the TECS protocol readers will be compared to the face to face physician, with the face to face serving as the standard of care. The results will be done with and without OCT. Sensitivity, specificity, positive and negative predictive value will be calculated before and after OCT.

Secondary Outcomes

  • Number of patients appropriately referred from the TECS protocol(Evaluation visit (Day 0))
  • Number of participants with an accurate diagnosis for anterior segment disease(Evaluation visit (Day 0))
  • Inter-reader variability of the TECS protocol(Evaluation visit (Day 0))
  • Intra-reader variability of the TECS protocol(Evaluation visit (Day 0))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

April Maa

Assistant Professor

Emory University

Study Sites (2)

Loading locations...

Similar Trials

Technology-based Eye Care Services (TECS)... | Clinical Trial